← Back to Search

Behavioral Intervention

EWM Training for ADHD

N/A
Recruiting
Led By Michael C Stevens, PhD
Research Sponsored by Hartford Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Must not have
Brain abnormality or neurological disorder
History of TBI or loss of consciousness exceeding 30 minutes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in scores from baseline assessment versus 5 weeks at the conclusion of training
Awards & highlights

Summary

This trial will check if the treatment engages with the intended target like in the first phase, and see if this engagement leads to actual improvements in ADHD symptoms.

Who is the study for?
This trial is for individuals diagnosed with ADHD. Specific eligibility criteria are not provided, so it's important to contact the study organizers for detailed information on who can participate.Check my eligibility
What is being tested?
The study is testing a training called EWM Training against a Placebo Training to see if it helps improve executive working memory and reduces symptoms of ADHD.See study design
What are the potential side effects?
Since the interventions involve training programs rather than medication, traditional side effects may not apply. However, participants might experience fatigue or frustration.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a brain condition or neurological disorder.
Select...
I have had a traumatic brain injury or was unconscious for over 30 minutes.
Select...
I have been diagnosed with a mental health condition like Psychosis, Bipolar Disorder, or PTSD.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in scores from baseline assessment versus 5 weeks at the conclusion of training
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in scores from baseline assessment versus 5 weeks at the conclusion of training for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Experimental executive working memory training tasks - Performance Accuracy
Experimental executive working memory training tasks - Reaction Time
Magnetic Resonance Imaging Functional Brain Scan using a Seimens 3T Skyra.
Secondary outcome measures
Conners Rating Scales 3rd Edition
Near/Far transfer tasks

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: ADHD EWMExperimental Treatment1 Intervention
Participants will receive EWM training sessions.
Group II: ADHD PlaceboPlacebo Group1 Intervention
Participants will receive placebo training sessions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
EWM Training
2021
N/A
~70

Find a Location

Who is running the clinical trial?

Hartford HospitalLead Sponsor
135 Previous Clinical Trials
18,956 Total Patients Enrolled
2 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
100 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Michael C Stevens, PhDPrincipal InvestigatorInstitute of Living/Hartford Hospital
2 Previous Clinical Trials
102 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
62 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
~87 spots leftby Aug 2026